Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.
By S. Hunger, Xiaomin Lu, M. Devidas, B. Camitta, P. Gaynon, N. Winick, G. Reaman, W. Carroll. Journal of Clinical Oncology, 2012
1,130 citations recorded by the source corpus.
Subfields: Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/c6db7d287408e187a9fe1148aef4e2f7c29d723f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Acute Lymphoblastic Leukemia in Children (2013, background): “among 21,626 people who were treated for childhood ALL in Children’s Oncology Group (COG) trials from 1990-2005 found a 10-year survival of almost 84% [124].”
- CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. (2015, background): “Overall survival for ALL in children exceeds 85%.(1) Improved survival primarily stems from decreased incidence of relapse, with very little improvement for more than twenty years in survival rates for children who relapse.”
- Toward the future of psychiatric diagnosis: the seven pillars of RDoC (2013, background): “Similarly, survival rates for children with acute lymphoblastic leukemia have improved over the last several decades from less than 10% to over 90% [12].”